Flagship Pioneering Associate Laura Lande-Diner Named to PharmaVOICE 100

Each year, PharmaVOICE celebrates men and women in the life sciences who inspire their colleagues and companies through leadership. The annual PharmaVOICE 100 issue profiles these individuals, their approaches to facing challenges and motivating teams, and their viewpoints on leading people and companies.

We are pleased to share that Laura Lande-Diner, an associate at Flagship Pioneering, has been named to the 2017 PharmaVOICE 100. Laura joined Flagship in 2016 after working at several Flagship VentureLabs® companies. She is the author of more than 10 peer-reviewed publications and an inventor on 11 patents and applications. She holds a Ph.D. in epigenetics and molecular biology from the Hebrew University of Jerusalem Medical School, where she studied mechanisms of long-term gene expression in mammalian cells.

Congratulations to Laura for her place on the PharmaVOICE 100 – read the profile article about Laura online here.